Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts

Developmental Neuroscience

Volumn 30, Issue 6, 2009, Pages 410-418

  Uto, Takuhiro ^a   Contreras, Miguel A ^a   Gilg, Anne G ^a   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cytokines; Lymphoblasts; NADPH oxidase; Neuroinflammation; Nitric oxide; Oxidative stress; Peroxisomal disorder; Tumor necrosis factor ; Very long chain fatty acids; X Adrenoleukodystrophy

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; MEVINOLIN; NITRIC OXIDE; PHENYLACETATE SODIUM; PHENYLACETIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; CELL LINE; CELL MEMBRANE; CHILD; CHILDHOOD ADRENOLEUKODYSTROPHY; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCHOOL CHILD; UPREGULATION;

ADRENOLEUKODYSTROPHY; CELL LINE; CHILD; FATTY ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-1BETA; LOVASTATIN; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NITRIC OXIDE; OXIDATION-REDUCTION; PHOSPHOPROTEINS; PROTEIN SUBUNITS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58749085411     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191212     Document Type: Article

References (40)

1. Wanders RJ, Waterham HR: Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006;75:295-332.
2. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, et al: Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-730.
3. Contreras M, Mosser J, Mandel JL, Aubourg P, Singh I: The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett 1994;344:211-215.
4. Contreras M, Sengupta TK, Sheikh F, Aubourg P, Singh I: Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes. Arch Biochem Biophys 1996;334:369-379.
5. Lazo O, Contreras M, Hashmi M, Stanley W, Irazu C, Singh I: Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA 1988;85:7647-7651.
6. Makkar RS, Contreras MA, Paintlia AS, Smith BT, Haq E, Singh I: Molecular organization of peroxisomal enzymes: protein-protein interactions in the membrane and in the matrix. Arch Biochem Biophys 2006;451:128-140.
7. Moser HW, Smith KD, Watkins PA, Powers J, Moser AB: X-Linked Adrenoleukodystrophy; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001, vol 2, pp 3257-3301.
8. Smith KD, Kemp S, Braiterman LT, Lu JF, Wei HM, Geraghty M, Stetten G, et al: X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res 1999;24:521-535.
9. Powers JM, Liu Y, Moser AB, Moser HW: The inflammatory myelinopathy of adrenoleukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992;51:630-643.
10. Gilg AG, Singh AK, Singh I: Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy. J Neuropathol Exp Neurol 2000;59:1063-1069.
11. Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I: Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 2003;14:425-439.
12. Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, et al: Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 1997;50:829-843.
13. Kobayashi T, Shinnoh N, Kondo A, Yamada T: Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997;232:631-636.
14. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD: A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 1997;94:9366-9371.
15. Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, Watkins PA, et al: Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005;64:1067-1079.
16. Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, Latini A, et al: Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 2004;1688:26-32.
17. Babior BM: NADPH oxidase: an update. Blood 1999;93:1464-1476.
18. Segal AW: How neutrophils kill microbes. Annu Rev Immunol 2005;23:197-223.
19. Brown GC: Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 2007;35:1119-1121.
20. Di Biase A, Merendino N, Avellino C, Cappa M, Salvati S: Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy. J Neurol Sci 2001;182:161-165.
21. Lannuzel A, Aubourg P, Tardieu M: Excessive production of tumour necrosis factor alpha by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy. Eur J Paediatr Neurol 1998;2:27-32.
22. Tiffany CW, Hoefler S, Moser HW, Burch RM: Arachidonic acid metabolism in fibroblasts from patients with peroxisomal diseases: response to interleukin 1. Biochim Biophys Acta 1990;1096:41-46.
23. Di Biase A, Di Benedetto R, Fiorentini C, Travaglione S, Salvati S, Attorri L, Pietraforte D: Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem Int 2004;44:215-221.
24. Knazek RA, Rizzo WB, Schulman JD, Dave JR: Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy. J Clin Invest 1983;72:245-248.
25. Ho JK, Moser H, Kishimoto Y, Hamilton JA: Interactions of a very long chain fatty acid with model membranes and serum albumin: implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 1995;96:1455-1463.
26. Whitcomb RW, Linehan WM, Knazek RA: Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 1988;81:185-188.
27. Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL: Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 2002;11:499-505.
28. Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, Kemp S, et al: Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 2008;17:1762-1773.
29. Khan M, Contreras M, Singh I: Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J Endotoxin Res 2000;6:41-50.
30. Feinstein DL, Galea E, Roberts S, Berquist H, Wang H, Reis DJ: Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 1994;62:315-321.
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
32. Singh I, Khan M, Key L, Pai S: Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med 1998;339:702-703.
33. Singh I, Pahan K, Khan M: Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy. FEBS Lett 1998;426:342-346.
34. Pai GS, Khan M, Barbosa E, Key LL, Craver JR, Cure JK, Betros R, et al: Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Mol Genet Metab 2000;69:312-322.
35. Robertson AK, Cross AR, Jones OT, Andrew PW: The use of diphenylene iodonium, an inhibitor of NADPH oxidase, to investigate the antimicrobial action of human monocyte derived macrophages. J Immunol Methods 1990;133:175-179.
36. Fujiki Y, Hubbard AL, Fowler S, Lazarow PB: Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982;93:97-102.
37. Rossary A, Arab K, Steghens JP: Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts. Biochem J 2007;406:77-83.
38. Shao D, Segal AW, Dekker LV: Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 2003;550:101-106.
39. Cui XL, Douglas JG: Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 1997;94:3771-3776.
40. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL: Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006;47:74-80.